These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 36267313)
21. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module. Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152 [TBL] [Abstract][Full Text] [Related]
22. Development and validation of a glioma prognostic model based on telomere-related genes and immune infiltration analysis. Liu X; Wang J; Su D; Wang Q; Li M; Zuo Z; Han Q; Li X; Zhen F; Fan M; Chen T Transl Cancer Res; 2024 Jul; 13(7):3182-3199. PubMed ID: 39145097 [TBL] [Abstract][Full Text] [Related]
23. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis. Pei J; Wang Y; Li Y J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983 [TBL] [Abstract][Full Text] [Related]
24. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer. Qiu C; Wang W; Xu S; Li Y; Zhu J; Zhang Y; Lei C; Li W; Li H; Li X BMC Cancer; 2024 Apr; 24(1):402. PubMed ID: 38561760 [TBL] [Abstract][Full Text] [Related]
25. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324 [TBL] [Abstract][Full Text] [Related]
26. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
27. Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma. Wang X; Luo X; Wang Z; Wang Y; Zhao J; Bian L Heliyon; 2023 Sep; 9(9):e19114. PubMed ID: 37662825 [TBL] [Abstract][Full Text] [Related]
28. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses. Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183 [TBL] [Abstract][Full Text] [Related]
29. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879 [TBL] [Abstract][Full Text] [Related]
30. Exploring the Prognostic Significance and Immunotherapeutic Potential of Single-Cell Sequencing-Identified Long Noncoding RNA (LncRNA) in Patients With Non-small Cell Lung Cancer. Chen L; Wang L; Xiong Z; Zhu X; Chen L Cureus; 2023 Nov; 15(11):e48436. PubMed ID: 38074028 [TBL] [Abstract][Full Text] [Related]
31. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061 [TBL] [Abstract][Full Text] [Related]
32. A novel focal adhesion-related risk model predicts prognosis of bladder cancer -- a bioinformatic study based on TCGA and GEO database. Hu J; Wang L; Li L; Wang Y; Bi J BMC Cancer; 2022 Nov; 22(1):1158. PubMed ID: 36357874 [TBL] [Abstract][Full Text] [Related]
33. Identification of biomarkers for acute leukemia via machine learning-based stemness index. Zhang Y; Liu D; Li F; Zhao Z; Liu X; Gao D; Zhang Y; Li H Gene; 2021 Dec; 804():145903. PubMed ID: 34411647 [TBL] [Abstract][Full Text] [Related]
34. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer. Feng S; Ning L; Zhang H; Wang Z; Lu Y PeerJ; 2024; 12():e17861. PubMed ID: 39119106 [TBL] [Abstract][Full Text] [Related]
35. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma. Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823 [No Abstract] [Full Text] [Related]
36. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
37. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
38. Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models. Fang Y; Zhang Q; Guo C; Zheng R; Liu B; Zhang Y; Wu J Front Immunol; 2024; 15():1461489. PubMed ID: 39380996 [TBL] [Abstract][Full Text] [Related]
39. An Apoptosis-Related Specific Risk Model for Breast Cancer: From Genomic Analysis to Precision Medicine. Li Z; Liu H; Zhang M; Wang J; Peng Q; Jiang N; Wei Y Front Biosci (Landmark Ed); 2024 Jun; 29(7):239. PubMed ID: 39082332 [TBL] [Abstract][Full Text] [Related]
40. Identification of the key genes of tuberculosis and construction of a diagnostic model via weighted gene co-expression network analysis. Li B; Sun L; Sun Y; Zhen L; Qi Q; Mo T; Wang H; Qiu M; Cai Q J Infect Chemother; 2023 Nov; 29(11):1046-1053. PubMed ID: 37499902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]